ADHD Doesn't MEASURE Up, JAZZ Abuzz, NBIX Slips On Failed Study

Alcobra Ltd.'s (ADHD) second phase III clinical trial of its investigational product Metadoxine Extended Release for the treatment of attention deficit hyperactivity disorder in adult patients has failed to meet the primary endpoint.

from RTT - Biotech http://ift.tt/2jmxGY7
via IFTTT